Health & Beauty

According to the observation report of Huacheng import and export data, recently, with the adjustment and optimization of epidemic prevention policies in many places in China, the market demand for anti fever, cough, antiviral and other COVID-19 drugs has increased significantly. In order to fully guarantee supply, Xinhua Pharmaceutical, Hendy Pharmaceutical, Humanwell Pharmaceutical, Hengrui Pharmaceutical, Jinshi Yayao, Jiudian Pharmaceutical, Zhongsheng Pharmaceutical and other A-share listed companies are coordinating resources internally to ensure that relevant production lines operate at full capacity 24 hours a day and release production capacity to the maximum extent; We will make efforts from multiple links, such as raw materials and transportation, and make every effort to ensure stable production and supply. Yifan Pharmaceutical and Xinhua Pharmaceutical will soon expand their core drug production capacity.

Coordinate resources to maximize capacity

"The company tries its best to mobilize all the forces that can be mobilized, adjust the intelligent production line, work 24 hours a shift without stopping, ensure the maximum release of production capacity, and fully guarantee the market supply of key drugs." He Tongqing, Party Secretary and Chairman of Xinhua Pharmaceutical, said.

According to the observation report of Huacheng import and export data, as an important production and export base of antipyretic and analgesic drugs in China, Xinhua ibuprofen tablets produced by Xinhua Pharmaceutical were the first to be listed in China in 1981, and the first to pass the consistency evaluation of generic drugs in 2020. In the Reference Table of Common Drugs for Home Treatment of COVID-19 Infected Persons (hereinafter referred to as the Reference Table of Common Drugs) issued by the joint prevention and control mechanism of the State Council, ibuprofen, acetaminophen, aspirin, loratadine, cetirizine and other drugs produced by Xinhua Pharmaceutical are all included in the list.

According to the observation report of Huacheng import and export data, at present, many intelligent production lines in the production workshop of Xinhua Pharmaceutical are operating at full speed. They work overtime to produce drugs urgently needed in the market, such as ibuprofen tablets and vitamin C tablets, to ensure market supply. "Hualu Group will fully support Xinhua Pharmaceutical, expand its production capacity to ensure market supply, and ensure that the production capacity of ibuprofen and other key drugs will double by the end of December." Fan Jun, Secretary of the Party Committee and Chairman of Hualu Group, said on December 15.

Hendy Pharmaceuticals, which has a production capacity of 3500 tons/year of ibuprofen API, also said that the company is actively cooperating with the relevant requirements of the national epidemic prevention policy, and is working hard to produce ibuprofen to ensure the market supply. At present, the production and operation are normal.

In the Yuan'an oral preparation workshop of Yichang Humanwell Pharmaceutical Co., Ltd., a subsidiary of Humanwell Pharmaceutical Holdings, the ibuprofen production line runs all the time; The production of acetaminophen tablets, compound paracetamol and amantadine capsules, pholcodine syrup and other drugs has also been stepped up in the park.

In order to better stabilize production and ensure supply, Yichang Humanwell Pharmaceutical Co., Ltd. strengthened organization and coordination on the basis of sorting out finished product inventory, raw material reserves, drug production capacity, transportation and sales, and further improved production capacity. All departments, such as raw material procurement, equipment maintenance, logistics and transportation, are on duty, and the production line starts the "three shift" working system to achieve 24-hour non-stop operation. At the same time, the staff of other parks will be deployed and supported to fully ensure the full operation of the drug production line in short supply.

For Jinshi Sub medicine, the conventional production plan was adjusted rapidly, and related production lines such as Compound Paracetamol and Alkylamine Capsules (Quick) started full load production mode to fully guarantee product supply. Jiudian Pharmaceutical said that the company's loxoprofen sodium tablets have been produced on a 24-hour shift to meet the market demand. Northeast Pharmaceutical said that acetaminophen and compound paracetamol and amantadine produced by the company have antipyretic effects. The company has stepped up the production of the aforementioned drugs and vitamin C series preparations according to market demand, and fully guaranteed market supply.

Take multiple measures to ensure supply and expand production

Ensuring the stability of raw materials is an essential link for drug enterprises to ensure stable production and supply or expand production. The reporter noted that many enterprises have acted quickly. Renhe Pharmaceutical said on the interactive platform that the company has taken various measures to ensure the production of its own products, while increasing the procurement of upstream raw and auxiliary materials and the transfer of OEM OEM products, and doing its best to ensure the stable supply of anti epidemic drugs.

The procurement department of Yichang Humanwell Pharmaceutical actively coordinated with the raw material suppliers, and the production department quickly arranged vehicles to the raw material manufacturers in other provinces to ensure that the raw materials, packaging and other materials are in place in time, and the production of drugs in short supply is scheduled in time. Yifan Pharmaceutical has set up an anti epidemic drug supply team earlier to conduct research on the model and strategy from the aspects of finished product inventory, raw material reserve, product capacity and transportation services.

"At present, the relevant production lines are all producing at full capacity. We are ensuring the supply of relevant anti epidemic products through overtime, CMO and expansion of production capacity." Yifan Pharmaceutical said when responding to investors' concerns on the interactive e-platform. According to Huacheng's import and export data observation report, the company's epidemic prevention related varieties mainly include Maqin Xiaoke Granules, ibuprofen dry suspension, ibuprofen tablets, etc.

At present, many production lines of the four preparation production plants in Yifan Pharmaceutical have been fully loaded, working shifts are non-stop, and personnel are managed in a closed loop to ensure the quality and output of core key varieties. Yifan Pharmaceutical said that the company is planning to accelerate the upgrading of production equipment, continue to expand production capacity, and maximize support for the drug demand of the public. It is expected that the output of key core varieties will increase significantly in the coming January.

Zhongsheng Pharmaceutical said that the production end of the company's ibuprofen tablets and other products has been fully produced, and it will try its best to meet the market demand. The company holds the production approval of acetaminophen oral solution and acetaminophen suppository, and will carry out production and sales according to the market situation.

Tianyuan Pharmaceutical, a subsidiary of Jin'an Guoji, is the largest drug manufacturer of Flos Trollii in China. Jin Anguoji said on the interactive e-platform that Tianyuan Pharmaceutical is currently in full production. Due to the large demand, the supply of products exceeds the demand. The Shenghe Chinese herbal medicine planting base owned by Tianyuan Pharmaceutical covers an area of more than 1700 mu, mainly planting trollius, and the supply of the original trollius medicinal materials is guaranteed.

Hengrui Pharmaceuticals, which owns ibuprofen suspension, ambroxol hydrochloride oral solution and other products, also actively expands its production capacity according to market demand, and takes multiple measures to expand production and ensure supply. After investigating the market demand, the company quickly launched "family protection package", "enterprise care package" and other standing drug kits, and integrated ibuprofen suspension, ambroxol hydrochloride oral solution, electrolyte water for special medical purposes and other products into a set for chain drugstores and other market terminals. At the same time, the company made emergency arrangements to sell on the shelves in flagship stores of major e-commerce platforms.

Yichang Humanwell Pharmaceutical comprehensively sorted out the product details and inventory, added the production plan of anti epidemic drugs according to market changes, issued a letter of priority guarantee medical institutions to customers of centralized procurement and distribution, and organized the supply of goods and logistics to meet the supply demand of anti epidemic materials. Huacheng reported the import and export data.